Suppr超能文献

CYP2D6和CYP3A5基因多态性对韩国精神分裂症患者血浆中利培酮及9-羟基利培酮浓度的影响。

Effects of CYP2D6 and CYP3A5 genotypes on the plasma concentrations of risperidone and 9-hydroxyrisperidone in Korean schizophrenic patients.

作者信息

Kang Rhee-Hun, Jung Sun-Min, Kim Kyoung-Ah, Lee Duk-Ki, Cho Hyun-Kee, Jung Bong-Joo, Kim Young-Ku, Kim Seung-Hyun, Han Changsu, Lee Min-Soo, Park Ji-Young

机构信息

Departments of Psychiatry, Korea University College of Medicine, Seoul, Korea.

出版信息

J Clin Psychopharmacol. 2009 Jun;29(3):272-7. doi: 10.1097/JCP.0b013e3181a289e0.

Abstract

This study was conducted to evaluate the effects of the CYP2D6 and CYP3A5 genotypes on the steady-state plasma levels of risperidone (RIS), 9-hydroxyrisperidone (9-OH-RIS), and the active moiety (RIS plus 9-OH-RIS) in Korean schizophrenic patients. Sixty-four Korean schizophrenic patients were enrolled. CYP2D6 and CYP3A5 genotypes were determined, and the plasma levels of RIS and 9-OH-RIS were measured using high-performance liquid chromatography. The dose-normalized plasma concentrations of RIS, 9-OH-RIS, and the active moiety were compared according to the CYP2D6 and CYP3A5 genotypes. Among the patients, 57 were CYP2D6 extensive metabolizers (EMs; CYP2D6*1/*1, *1/*10, and *10/10) and 7 were CYP2D6 poor metabolizers (PMs; CYP2D61/*5 and *10/5). For the CYP3A5 genotype, 30 patients were CYP3A51 expressors (*1/*1 [n = 1] and *1/*3 [n = 29]) and 34 patients were CYP3A5 nonexpressors (*3/*3). The plasma levels of RIS (2.03 ng/mL per milligram for EMs vs 5.57 ng/mL per milligram for PMs, P < 0.001) and 9-OH-RIS (5.06 ng/mL per milligram for EMs vs 0.22 ng/mL per milligram for PMs, P < 0.001) were significantly different among CYP2D6 genotype groups, but the CYP2D6 EMs (7.09 ng/mL per milligram) and PMs (5.79 ng/mL per milligram) did not show no difference in the levels of the active moiety (P = 0.470). CYP3A5 nonexpressors exhibited higher plasma concentrations of both RIS and 9-OH-RIS than its expressors. In the case of 9-OH-RIS, CYP3A5 nonexpressors exhibited significantly higher concentrations than CYP3A5 expressors (5.42 vs 3.51 ng/mL per milligram, P = 0.022). In addition, concentrations of the active moiety were also significantly different between the CYP3A5 nonexpressors (8.39 ng/mL per milligram) and expressors (5.30 ng/mL per milligram, P = 0.005). In conclusion, both CYP2D6 and CYP3A5 genotypes affected plasma levels of RIS and 9-OH-RIS, whereas the active moiety levels were influenced only by the CYP3A5 genotype but not by the CYP2D6 genotype.

摘要

本研究旨在评估CYP2D6和CYP3A5基因多态性对韩国精神分裂症患者中利培酮(RIS)、9-羟基利培酮(9-OH-RIS)及活性部分(RIS加9-OH-RIS)稳态血药浓度的影响。纳入64例韩国精神分裂症患者。测定CYP2D6和CYP3A5基因多态性,并采用高效液相色谱法测定RIS和9-OH-RIS的血药浓度。根据CYP2D6和CYP3A5基因多态性比较RIS、9-OH-RIS及活性部分的剂量标准化血药浓度。患者中,57例为CYP2D6广泛代谢型(EMs;CYP2D6*1/*1、*1/10和10/10),7例为CYP2D6慢代谢型(PMs;CYP2D61/5和10/5)。对于CYP3A5基因多态性,30例患者为CYP3A51表达型(*1/1 [n = 1]和1/*3 [n = 29]),34例患者为CYP3A5非表达型(*3/*3)。CYP2D6基因多态性组间RIS(EMs为每毫克2.03 ng/mL,PMs为每毫克5.57 ng/mL,P < 0.001)和9-OH-RIS(EMs为每毫克5.06 ng/mL,PMs为每毫克0.22 ng/mL,P < 0.001)的血药浓度有显著差异,但CYP2D6 EMs(每毫克7.09 ng/mL)和PMs(每毫克5.79 ng/mL)的活性部分水平无差异(P = 0.470)。CYP3A5非表达型患者的RIS和9-OH-RIS血药浓度均高于表达型患者。就9-OH-RIS而言,CYP3A5非表达型患者的浓度显著高于CYP3A5表达型患者(每毫克5.42 vs 3.51 ng/mL,P = 0.022)。此外,CYP3A5非表达型患者(每毫克8.39 ng/mL)和表达型患者(每毫克5.30 ng/mL,P = 0.005)的活性部分浓度也有显著差异。总之,CYP2D6和CYP3A5基因多态性均影响RIS和9-OH-RIS的血药浓度,而活性部分水平仅受CYP3A5基因多态性影响,不受CYP2D6基因多态性影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验